INTRODUCTION
============

Vitamin A is an essential component of the human diet. It is derived from vitamin-A-rich foods as well as from foods containing beta-carotene, composed of two retinol molecules.^[@r1]^ Retinoic acid (RA) is the active metabolite of vitamin A and is a critical signaling molecule for both the developing and adult central nervous system (CNS). RA is synthesized more by the CNS than by any other organ and has long been recognized as a crucial factor for controlling the differentiation program of certain cells.^[@r2]^ RA is produced from the irreversible oxidation promoted by retinaldehyde dehydrogenase (RALDH). This enzyme is present in three distinctive isoforms (RALDH1, RALDH2 and RALDH3), which display non-overlapping tissue-specific patterns of expression during embryogenesis.^[@r3]^ Vitamin A deficiency could result in impaired cellular differentiation, reduced resistance to infection, anemia and, ultimately, death. In fact, vitamin A deficiency is a serious health problem in developing nations.^[@r4],[@r5]^

One of the most interesting aspects of RA in the brain is in relation to memory. The complexity of RA involvement in memory is such that either too much or too little can result in similar deficits in learning behaviors.^[@r6]^ Retinoic acid is broadly implicated in neurogenesis, plasticity, cell differentiation and synaptic connectivity, but RA levels must be maintained at moderate levels through complex feedback control for appropriate learning.^[@r6]^ It might be said that excessive plasticity could be detrimental for effective learning and consolidation of very specific patterns and tasks. Most knowledge on vitamin A and memory is derived from animal studies and this field of research is set to remain open for many years to come. However, even without evidence-based data, the appeal of vitamin supplementation for prevention and treatment of cognitive dysfunction in adults can be problematic. In children, vitamin A supplementation has saved many lives^[@r7],[@r8]^ yet has endangered others.^[@r9],[@r10]^ In adults supplementing their diets with vitamin capsules, the problem has yet to be properly assessed. Whether vitamin A is related to memory functions and whether its supplementation can yield benefits in a clinical setting remains to be established. A case-control study in the early 1990s suggested that Alzheimer\'s disease might be associated to low levels of vitamin A and beta-carotene.^[@r11]^ Twenty years on, and with much more research having been carried out in this field,^[@r12]^ there is still a lack of clinical trials assessing the effects of vitamin A and cognition.

The present systematic review was conducted with the aim of collecting and organizing data in the literature on the subject of vitamin A and memory.

METHODS
=======

This systematic review of the literature followed the strict guidelines set forth by the PRISMA group.^[@r13]^ There were no meta-analyses of the data since the present report intended to be essentially descriptive and qualitative. No approval from the Ethics Committee was required since the study was carried out solely with published data from the world literature. The present study was registered as a scientific project at the Research Center of Universidade Metropolitana de Santos, SP, Brazil.

Using the PICO framework,^[@r14]^ the authors independently searched for the terms \"vitamin A\" OR \"retinol\" OR \"retinoic acid\" AND \"memory\" OR \"cognition\" OR \"Alzheimer\" in the following databases: Medline, Pubmed, Scopus, Index Medicus, Biomed Central, Ebsco Fulltext, LILACS, Scielo and the Cochrane Database of Systematic Reviews. Abstracts of articles in any language that contained these words in English (in the title, key words or abstract) were independently reviewed by the authors. The latest date of publication for inclusion of articles in the study was 10^th^ July 2012.

The inclusion criterion was to evaluate papers presenting original work and reviews on aspects of memory that were related to vitamin A. Studies on animals and humans were both included. However, research concentrating only on cell line cultures was not included in this review.

Studies reporting indirect evidence of the role of vitamin A and memory, for example the effect of this vitamin on the formation of plaques or fibrils, were also considered to be relevant to the present review, and were therefore included.

Abstracts from scientific meetings, anecdotal case reports, duplicate papers and editorials were excluded. Papers reporting exclusively on social behavior and/or sleep patterns relating to vitamin A were also excluded. Studies reporting on the role of RA in regenerating axolotl limbs or immunological lymphocyte memory patterns were also excluded, since these were not related to the \"memory\" aspect of the present paper (which was essentially one of cognition).

A recent systematic review has concluded that isotretinoin (13-cis-RA) is related to severe mood disorders in humans.^[@r15]^ Therefore, all papers reporting on the psychiatric aspects of vitamin A were excluded from the present review.

Papers reporting on the effect of \"carotenoids\" and/or \"antioxidants\" in general were also not included, as the present review concentrated exclusively on vitamin A.

All abstracts obtained retrieved using the specific key words were read individually by three of the authors. Once they had agreed on the abstracts that complied with the inclusion criteria, the full papers were obtained. Reference lists from the selected papers were checked to search for other possible relevant publications. The articles selected for the systematic review were read and summarized by the author who had not participated in the initial selection of abstracts.

RESULTS
=======

The initial search yielded 236 papers containing the specific key words. From these studies, 88 were selected for full reading of the text. The remaining 148 papers did not fulfill the inclusion criteria. Of the 88 papers initially selected, 44 were selected for this review.

The period of the literature search was open, but the initial study included in the present review dated from 1997, when Enderlin et al^[@r15]^ reported that RA could be involved in the alterations of synaptic plasticity observed in elderly mice. At the same time, Connor & Sidell^[@r16]^ reported on the activity of RALDHs in the human hippocampus in controls and individuals with Alzheimer\'s disease. In 1998, Chiang et al.^[@r18]^ reported a pattern of RA and plasticity by studying spatial learning and memory tasks. These authors stated that a novel and unexpected role for vitamin A was thus observed for higher cognitive functions. These studies published in the late 1990s were the first included in the present review. After these studies, many others ensued and a summary of these is given in Table 1. Ten reviews were identified among the publications,^[@r12],[@r29],[@r30],[@r32],[@r34],[@r37],[@r45]-[@r47],[@r51]^ while 34 papers presented original data.^[@r15]-[@r28],[@r31],[@r33]-[@r36],[@r38]-[@r44],[@r48]-[@r50],[@r52]-[@r57]^

The animal models for studying vitamin A and cognition were birds, mice and rats. The human studies consisted of two reports on brain tissue from autopsies^[@r16],[@r54]^ and one paper on the role of isotretinoin in cognition among individuals taking this medication to treat acne.^[@r50]^

DISCUSSION
==========

The studies on vitamin A and cognition, according to this systematic review, point to a role for RA in higher mental function. From learning simple tasks to establishing memory patterns, animals performed better with supplementation of vitamin A and worse in its absence from the diet. However, excessive amounts of vitamin A had a detrimental effect on the pattern of vocally learned processes in birds. This is an important point to consider, since some \"treatments\" for cognitive dysfunction in humans have historically envisaged excessive doses of vitamins.

From the first studies^[@r17]^ to the latest papers,^[@r57]^ long-term potentiation (LTP) and long-term depression (LTD) in the hippocampus appear to be positively affected by RA. LTP and LTD are cellular mechanisms for learning and memory and are therefore critical for cognition. It has been demonstrated that RA can increment LTP and LTD,^[@r56]^ inhibit the deposition of beta amyloid,^[@r25],[@r26],[@r38]^ while also have anti-oxidative, cell protective and anti-aggregation effects.^[@r51]^ At least in mice, RA seems to be distributed differently in the layers of the dentate gyrus of the hippocampus,^[@r57]^ and the functional implications of this finding could be linked to RA-regulated transcription.

RA receptors and related enzymes are present in the human hippocampus^[@r16],[@r54]^ and may be significantly affected by Alzheimer\'s disease.^[@r16]^ Therapeutic effects of vitamin A supplementation for protection against this dementia are a real possibility and clinical trials should be carried out in order to assess the efficacy and safety of vitamin A supplementation for the prevention and treatment of Alzheimer\'s disease. This matter must be investigated with scientific rigor, as the indiscriminate use of vitamin A supplementation for treatment (or prevention) of Alzheimer\'s disease is currently not based on scientific and/or medical evidence.

To conclude, vitamin A has been shown to have positive effects on cognition. Data on humans are scarce and no controlled studies have yet been carried out. Therefore, no recommendation for dietary supplementation with vitamin A can be proposed at this time with the purpose of preventing or treating Alzheimer\'s disease and/or other dementias. However, results from the studies summarized in this systematic review are encouraging and suggest a potential therapeutic effect of this vitamin in humans.
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